Alberto Costa

Professor

Case Western Reserve University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Alberto Costa is a faculty member at Case Western Reserve University in the United States. His research primarily focuses on Down syndrome, encompassing areas such as therapeutic interventions, gait dynamics, and neurophysiological biomarkers. He has contributed to various scholarly articles, including studies on cognitive outcomes and the impact of COVID-19 on individuals with Down syndrome. His work aims to advance understanding and improve treatment options for this population.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (10)

Monica Lakhanpaul

University College London

UNITED KINGDOM

View details

Susan Kozawa

Case Western Reserve University

UNITED STATES

View details

Andre Strydom

King’s College London

UNITED KINGDOM

View details

Melissa Stasko

Case Western Reserve University

UNITED STATES

View details

John S. Svendsen

UiT Norges arktiske universitet

NORWAY

View details

Richard Engh

University of Tromsø - The Arctic University of Norway

NORWAY

View details

Anke Hüls

Assistant Professor

Emory University School of Public Health

UNITED STATES

View details

Eugenio Barone

Associate Professor

Sapienza University of Rome

ITALY

View details

Li Chan

Professor of Molecular Endocrinology and Metabolism/Honorary Consultant in Paediatric Endocrinology

UNITED KINGDOM

View details

Giuseppina Sgandurra

University of Pisa

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alberto Costa

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society.

On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective

Emergence of Treadmill Running Ability and Quantitative Assessment of Gait Dynamics in Young Ts65Dn Mice: A Mouse Model for Down Syndrome

Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey.

Bio-Mimicking, Electrical Excitability Phenomena Associated With Synthetic Macromolecular Systems: A Brief Review With Connections to the Cytoskeleton and Membraneless Organelles.

COVID-19 Vaccination of Individuals with Down Syndrome—Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated

Evidence of Energy Metabolism Alterations in Cultured Neonatal Astrocytes Derived from the Ts65Dn Mouse Model of Down Syndrome

Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial.

Toward the Identification of Neurophysiological Biomarkers for Alzheimer’s Disease in Down Syndrome: A Potential Role for Cross-Frequency Phase-Amplitude Coupling Analysis

Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome

COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

Atypical electrophysiological and behavioral responses to diazepam in a leading mouse model of Down syndrome.

Collaborators (10)

Monica Lakhanpaul

Susan Kozawa

Andre Strydom

Melissa Stasko

John S. Svendsen

Richard Engh

Anke Hüls

Eugenio Barone

Li Chan

Giuseppina Sgandurra

Make your next move.

Alberto Costa

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society.

On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective

Emergence of Treadmill Running Ability and Quantitative Assessment of Gait Dynamics in Young Ts65Dn Mice: A Mouse Model for Down Syndrome

Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey.

Bio-Mimicking, Electrical Excitability Phenomena Associated With Synthetic Macromolecular Systems: A Brief Review With Connections to the Cytoskeleton and Membraneless Organelles.

COVID-19 Vaccination of Individuals with Down Syndrome&mdash;Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated

Evidence of Energy Metabolism Alterations in Cultured Neonatal Astrocytes Derived from the Ts65Dn Mouse Model of Down Syndrome

Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial.

Toward the Identification of Neurophysiological Biomarkers for Alzheimer’s Disease in Down Syndrome: A Potential Role for Cross-Frequency Phase-Amplitude Coupling Analysis

Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome

COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

Atypical electrophysiological and behavioral responses to diazepam in a leading mouse model of Down syndrome.

Collaborators (10)

Monica Lakhanpaul

Susan Kozawa

Andre Strydom

Melissa Stasko

John S. Svendsen

Richard Engh

Anke Hüls

Eugenio Barone

Li Chan

Giuseppina Sgandurra

Make your next move.

COVID-19 Vaccination of Individuals with Down Syndrome—Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated